The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

Article abstract MRI is very sensitive in showing MS lesions throughout the CNS. Using MRI for diagnostic purposes, however useful, is a complex issue because of limited specificity of findings and a variety of options as to when, how, and which patients to examine. Comparability of data and a common view regarding the impact of MRI are needed. Following a review of the typical appearance and pattern of MS lesions including differential diagnostic considerations, we suggest economic MRI examination protocols for the brain and spine. Recommendations for referral to MRI consider the need to avoid misdiagnosis and the probability of detecting findings of diagnostic relevance. We also suggest MRI classes of evidence for MS to determine the diagnostic weight of findings and their incorporation into the clinical evaluation. These proposals should help to optimize and standardize the use of MRI in the diagnosis of MS.

[1]  R. Herndon,et al.  Use of magnetic resonance imaging in the diagnosis of multiple sclerosis , 1986, Neurology.

[2]  J H Simon,et al.  Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. , 1986, Radiology.

[3]  B E Kendall,et al.  Magnetic resonance imaging of the optic nerve in optic neuritis , 1988, Neurology.

[4]  A. A. Eisen,et al.  MRI in the diagnosis of MS , 1988, Neurology.

[5]  J. Kurtzke.  Multiple sclerosis , 1988, Neurology.

[6]  H Lechner,et al.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis , 1988, Neurology.

[7]  A. L. Horowitz,et al.  The ovoid lesion: a new MR observation in patients with multiple sclerosis. , 1989, AJNR. American journal of neuroradiology.

[8]  I. Moseley,et al.  Acute disseminated encephalomyelitis , 2016, Neurology.

[9]  J. Taveras,et al.  Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. , 1991, Radiology.

[10]  A. Thompson,et al.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[11]  D. Li,et al.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2‐year follow‐up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT , 1991, Neurology.

[12]  W. Mcdonald,et al.  Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. , 1992, Brain : a journal of neurology.

[13]  A. Thompson,et al.  Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration , 1992, Neurology.

[14]  F. Barkhof,et al.  A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone , 1992, Neurology.

[15]  Roland Martin,et al.  Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.

[16]  D. Miller,et al.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.

[17]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[18]  A. Thompson,et al.  Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.

[19]  B. Stern,et al.  Intramedullary spinal sarcoidosis , 1993, Neurology.

[20]  A. Thompson,et al.  Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.

[21]  F. Barkhof,et al.  Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. , 1993, Brain : a journal of neurology.

[22]  F. Fazekas,et al.  Assessment of MRI criteria for a diagnosis of MS , 1993, Neurology.

[23]  H. McFarland,et al.  Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions , 1993, Annals of neurology.

[24]  R. Beck,et al.  Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. , 1993, Archives of neurology.

[25]  W. I. McDonald,et al.  Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.

[26]  Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. , 1994, Radiology.

[27]  W G Bradley,et al.  Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. , 1995, Radiology.

[28]  M. Rovaris,et al.  Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. , 1995, AJNR. American journal of neuroradiology.

[29]  Massimo Filippi,et al.  Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis , 1995, Journal of the Neurological Sciences.

[30]  R. Knobler,et al.  Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. , 1995, Radiology.

[31]  C. Polman,et al.  The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. , 1995, AJNR. American journal of neuroradiology.

[32]  M. Sanders,et al.  High resolution magnetic resonance imaging of the anterior visual pathway in patients with optic neuropathies using fast spin echo and phased array local coils. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[33]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[34]  W. I. McDonald,et al.  Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis , 1996, Neurology.

[35]  G J Barker,et al.  Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters , 1996, Journal of magnetic resonance imaging : JMRI.

[36]  M. Horsfield,et al.  Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[37]  I. Mader,et al.  Acute disseminated encephalomyelitis: MR and CT features. , 1996, AJNR. American journal of neuroradiology.

[38]  A. Thompson,et al.  Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.

[39]  D. Prayer,et al.  Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. , 1996, AJNR. American journal of neuroradiology.

[40]  F. Barkhof,et al.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.

[41]  C Becker,et al.  Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. , 1996, Brain : a journal of neurology.

[42]  A. Thompson,et al.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.

[43]  M. Rovaris,et al.  Sensitivity and Reproducibility of Fast‐FLAIR, FSE, and TGSE Sequences for the MRI Assessment of Brain Lesion Load in Multiple Sclerosis: A Preliminary Study , 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[44]  A J Thompson,et al.  PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS , 1997 .

[45]  J. Simon.  Contrast‐enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis , 1997, Journal of magnetic resonance imaging : JMRI.

[46]  J. Drulovic,et al.  A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency , 1997, Neurology.

[47]  P. Scheltens,et al.  MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.

[48]  F Barkhof,et al.  Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. , 1997, Magnetic resonance imaging.

[49]  G J Barker,et al.  Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. , 1997, Brain : a journal of neurology.

[50]  A. Thompson,et al.  Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast flair and fast spin echo , 1997, Journal of Neurology.

[51]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[52]  M Filippi,et al.  Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1‐‐‐weighted MRI , 1998, Neurology.

[53]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[54]  S Warach,et al.  The role of techniques characterised by faster acquisition times in the evaluation of multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[55]  J. K. Udupa,et al.  Isolated U-fiber involvement in MS , 1998, Neurology.

[56]  A. Thompson,et al.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.

[57]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[58]  F. Barkhof,et al.  Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.

[59]  J A Frank,et al.  Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis , 1998, Annals of neurology.

[60]  I. Moseley,et al.  Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination , 1998, Journal of neurology, neurosurgery, and psychiatry.

[61]  P. Serdarog̃lu.  Behçet’s disease and the nervous system , 1998, Journal of Neurology.

[62]  R I Grossman,et al.  Perspectives on multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.

[63]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[64]  Ludwig Kappos,et al.  Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.

[65]  J K Udupa,et al.  MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing. , 1999, AJNR. American journal of neuroradiology.